Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Auditor change
KalVista Pharmaceuticals, Inc. (KALV) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/10/2020 8-K Quarterly results
12/03/2019 8-K Quarterly results
Docs: "”"
09/09/2019 8-K Quarterly results
03/14/2019 8-K Quarterly results
Docs: "KalVista Pharmaceuticals Reports Fiscal Third Quarter Results – Oral Hereditary Angioedema Candidate KVD900 Phase 2 Trial Progressing – – Intravitreal Diabetic Macular Edema Candidate KVD001 Phase 2 Trial Completion Expected H2 2019 –"
12/14/2018 8-K Quarterly results
Docs: "KalVista Pharmaceuticals Reports Fiscal Second Quarter Results – KVD900 Enlarged Phase 2 Trial on Track for Potential On-Demand Treatment of Attacks in Patients with Hereditary Angioedema –"
07/31/2018 8-K Quarterly results
Docs: "KalVista Pharmaceuticals Inc.",
"Corporate presentation slide deck"
07/27/2017 8-K Quarterly results
Docs: "KalVista Pharmaceuticals Provides Operational Update and Reports Fiscal Fourth Quarter and Full Year Financial Results"
03/16/2017 8-K Quarterly results
Docs: "FORM 8-K",
"KalVista Pharmaceuticals Reports Fiscal Third Quarter Results"
11/12/2015 8-K Form 8-K - Current report
08/12/2015 8-K Form 8-K - Current report
05/21/2015 8-K Form 8-K - Current report

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy